Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
PanGenomic Health, Inc. Class A ( (TSE:NARA) ) has provided an announcement.
PanGenomic Health Inc. announced the resignation of Tammy Gillis as CFO, who will continue as a financial consultant to assist with the year-end audit. Francisco Kent Carasquero, a current director and former VP Finance, will assume the role of CFO. Carasquero brings extensive experience from the financial services industry, having held executive positions in fintech and advisory services, which could strengthen PanGenomic’s financial operations and strategic positioning.
More about PanGenomic Health, Inc. Class A
PanGenomic Health is a precision health company that offers a self-care digital platform focused on delivering personalized, evidence-based information about natural treatments. The company’s primary focus is on supporting mental health by providing plant-based solutions tailored to individual health profiles. As a British Columbia benefit company, PanGenomic Health aims to enhance health and wellness through its technology platform.
YTD Price Performance: 100.0%
Average Trading Volume: 27,132
Technical Sentiment Signal: Buy
Current Market Cap: C$1.54M
See more insights into NARA stock on TipRanks’ Stock Analysis page.